To test this hypothesis, mammary tumours were analysed for the expression of NF-κB downstream genes, known to be operative in the recruitment of myeloid cells, including Ccl3, Cxcl2, Il6, SPP1, IL-23 and TNFα35–38. This evidence concerns the gene CCL3 and breast cancer.